Moreover, after the stop of gefitinib treatment, we observed no tumor growth up to 40 days in control group (Figure 5A) but tumor grow again within 1 month in PHLPP knockdown group (Figure 5B). This evidence concerns the gene PHLPP1 and neoplasm.